JPH0582367B2 - - Google Patents

Info

Publication number
JPH0582367B2
JPH0582367B2 JP14968883A JP14968883A JPH0582367B2 JP H0582367 B2 JPH0582367 B2 JP H0582367B2 JP 14968883 A JP14968883 A JP 14968883A JP 14968883 A JP14968883 A JP 14968883A JP H0582367 B2 JPH0582367 B2 JP H0582367B2
Authority
JP
Japan
Prior art keywords
immunoglobulin
solution
polyethylene glycol
precipitate
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP14968883A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6042336A (ja
Inventor
Yasuo Shibata
Takeshi Suehiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON SEIYAKU KK
Original Assignee
NIPPON SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON SEIYAKU KK filed Critical NIPPON SEIYAKU KK
Priority to JP14968883A priority Critical patent/JPS6042336A/ja
Priority to DE19843430320 priority patent/DE3430320A1/de
Publication of JPS6042336A publication Critical patent/JPS6042336A/ja
Publication of JPH0582367B2 publication Critical patent/JPH0582367B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP14968883A 1983-08-18 1983-08-18 免疫グロブリンの製造方法 Granted JPS6042336A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP14968883A JPS6042336A (ja) 1983-08-18 1983-08-18 免疫グロブリンの製造方法
DE19843430320 DE3430320A1 (de) 1983-08-18 1984-08-17 Verfahren zur herstellung von immunglobulin-praeparaten mit verminderter komplementaktivitaet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14968883A JPS6042336A (ja) 1983-08-18 1983-08-18 免疫グロブリンの製造方法

Publications (2)

Publication Number Publication Date
JPS6042336A JPS6042336A (ja) 1985-03-06
JPH0582367B2 true JPH0582367B2 (enExample) 1993-11-18

Family

ID=15480636

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14968883A Granted JPS6042336A (ja) 1983-08-18 1983-08-18 免疫グロブリンの製造方法

Country Status (2)

Country Link
JP (1) JPS6042336A (enExample)
DE (1) DE3430320A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
DK2272870T3 (da) 1998-06-09 2013-08-05 Csl Behring Ag Fremgangsmåde til fremstilling af immunoglobuliner med henblik på intravenøs indgivelse og andre immunoglobulin-lignende produkter.
US6441144B1 (en) * 1999-05-20 2002-08-27 Alpha Therapeutic Corporation Method for repairing dual virally inactivated immune globulin for intravenous administration
JP2005320248A (ja) * 2002-04-22 2005-11-17 Mitsubishi Pharma Corp 免疫グロブリン製剤の製造方法
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI320788B (en) * 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
CA2788863C (en) 2010-02-04 2020-07-07 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
MX388043B (es) 2014-12-03 2025-03-19 Csl Behring Ag Producto farmacéutico con estabilidad incrementada que comprende inmunoglobulinas.

Also Published As

Publication number Publication date
DE3430320A1 (de) 1985-03-28
JPS6042336A (ja) 1985-03-06

Similar Documents

Publication Publication Date Title
CA1329542C (en) Plasma and recombinant protein formulations in low ionic strength media
KR970010923B1 (ko) 혈장단백질의 크로마토그래피 분리법
EP0314095B1 (en) Plasma and recombinant protein formulation in high ionic strength media
US6835379B2 (en) Method of producing IgG
US3631018A (en) Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
CN1044121C (zh) 分离凝血因子viii配合物的方法
KR100201195B1 (ko) 알부민 제제 및 이의 제조방법
JPS6030291B2 (ja) 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JPS597693B2 (ja) 抗トロンビン製剤及びその製法
AU2001273907A1 (en) A method of producing IgG
JPH0768137B2 (ja) アルブミン製剤及びその製法
JPH0582367B2 (enExample)
JPH0676337B2 (ja) 高純度抗血友病性因子濃縮物の製造法
JPH0580455B2 (enExample)
JPS58201794A (ja) ヒトインターフェロンβの濃縮精製法
HU204282B (en) Process for producing albumine-solutions purified with anionic detergent
JPS6236326A (ja) 造血器疾患治療剤
US4075197A (en) Serum albumin production
JPS61189228A (ja) 血液凝固第８因子製剤の製法
JPH0611705B2 (ja) 血小板減少症治療剤
JPH03218399A (ja) 尿由来の抗血液疑固物質、その製法およびそれを含有する医薬組成物
JPH06135851A (ja) コンドロイチナーゼ組成物およびそれを含有する注射用製剤
JPH08225599A (ja) Ｃ１−エステラーゼ阻害剤濃厚物（ｃ１−ｉｎｈ）の調製法、および治療的使用のための得られた濃厚物
CA1335369C (en) Process for the purification and pasteurization of urokinase
JPS597695B2 (ja) 免疫制御作用を有するペプタイド製剤